Salt CompositionEtofylline 169.4mg + Theophylline 50.6mg
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Treatment of Chronic obstructive pulmonary disease (COPD)
Customers also bought
More About Bronkofylin 169.4mg/50.6mg Injection
Benefits
In Treatment of Chronic obstructive pulmonary disease (COPD) Bronkofylin 169.4mg/50.6mg Injection helps the airways in your lungs stay open. It relaxes the muscles of these airways. This makes it easier for air to get in and out. It will relieve symptoms such as tightness in your chest, shortness of breath, wheezing and coughing and help you carry out your daily activities more easily. This medicine is safe and effective. It usually starts to work within a few minutes and the effects can last up to several hours. Do not stop using it unless you are advised to by your doctor.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How it works
Bronkofylin 169.4mg/50.6mg Injection is a combination of two bronchodilators: Etofylline and Theophylline. They work by relaxing the muscles in the airways and widen the airways. This makes breathing easier.
Unsafe: Avoid consuming alcohol with Bronkofylin 169.4mg/50.6mg Injection as it is deemed unsafe.
Seek medical advice from your doctor: Bronkofylin 169.4mg/50.6mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: Bronkofylin 169.4mg/50.6mg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby. Avoiding breastfeeding for 2-4 hours after Bronkofylin 169.4mg/50.6mg Injection can further decrease the exposure of medicine to the baby.
Seek medical advice from your doctor: It is not known whether Bronkofylin 169.4mg/50.6mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Seek medical advice from your doctor: There is limited information available on the use of Bronkofylin 169.4mg/50.6mg Injection in patients with kidney disease. Doctor consultation is advised.
Caution Advised: Bronkofylin 169.4mg/50.6mg Injection should be used with caution in patients with liver disease. Dose adjustment of Bronkofylin 169.4mg/50.6mg Injection may be needed. Doctor consultation is advised.
What if I forget to take it?
If a dose of Bronkofylin 169.4mg/50.6mg Injection is missed, it's advisable to consult your doctor.
Manufacturer Address
5/2 INDUSTRIAL AREA, KIRTI NAGAR, NEW DELHI - 110015
References
MedIndia. Theophylline + Etophylline (23 Apr. 2019)
PubChem. Etofylline (01 Apr. 2019)
Theophylline. Lake Forest, Illinois: Hospira, Inc.; 2008 (01 Apr. 2019)
Drugs.com. Etofylline (01 Apr. 2019)
ScienceDirect. Theophylline (23 Apr. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
